RARA and acute myeloid leukemia: Notably, this study also found that FTO expression can be upregulated by certain oncogenic proteins, such as MLL fusion proteins, PML-RARA, FLT3-ITD, and NPM1 mutants, leading to abnormally high levels of FTO in these AML subtypes.